Clarifying the Optimal Application of SLT Therapy Trial
Summary
- Eligibility
- for people ages 18 years and up (full criteria)
- Location
- at San Francisco, California and other locations
- Dates
- study startedestimated completion
- Principal Investigator
- by Ying Han, MD
Description
Summary
Keywords
Eligibility
Locations
Lead Scientist at UCSF
- Ying Han, MD
Dr. Ying Han is an ophthalmologist who specializes in treating glaucoma, including medical, laser and surgical therapies. She has expertise in evaluating and treating cataracts as well. In her research, Han evaluates new drug delivery and new surgical procedures for glaucoma. She's also interested in screening and treatment of glaucoma to prevent vision loss.
Details
- Status
- accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- West Virginia University
- ID
- NCT04967989
- Phase
- Phase 3 research study
- Study Type
- Interventional
- Participants
- Expecting 640 study participants
- Last Updated